Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-13

Clinical Trial Update: Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes [NA]

View source ↗

Summary

A clinical trial registry entry recruiting to promote alternatives to sulfonylureas to improve patient safety in Type 2 diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ian J. Neeland, MD | Conditions: Type2diabetes | NA | Status: RECRUITING